Autopsy report · NCT03796195

(SGB) in Men Treated for Prostate Cancer Improve Hot Flashes

“Enrollment issues”

The sponsor’s own words in the registry.

Life of this trial

• Registered 10 months before it started.
• Ran for about 1 year 8 months before it stopped.
• 1 participant enrolled.
• Results were posted on the registry 1 year 6 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

Northwestern University

Sponsor type

University, hospital or other

Conditions

Prostate Cancer; Hot Flashes

Interventions

.5% Bupivacaine

Participants

1

Sites

1

Countries

United States

Trials that died the same way

• Maintenance Dosing of Vitamin D in Crohn's Disease
  “Difficulties with enrollment” (92% match in meaning)
• Clinical Trial With Mesalamine 1g Suppositories
  “Enrollment difficulties” (92% match in meaning)
• Multicentric Study Comparison Between Erythropoietin and Erythropoietin Associated to Differentiating Therapy With Acid 13-cis-retinoic and Dihydroxyvitamin D3 in Myelodysplastic Syndromes Without Excess of Blasts
  “Difficulties of enrollment” (91% match in meaning)
• Effectiveness and Safety of Spondylitis Related to Inflammatory Bowel Disease
  “Difficulty with enrollment” (90% match in meaning)
• Efficacy and Safety of Zoledronic Acid in Acute Spinal Cord Injury: Prevention of Bone Loss
  “difficulty in enrollment” (88% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.